
Tara L. Martinez
Examiner (ID: 11484, Phone: (571)270-1470 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 712 |
| Issued Applications | 367 |
| Pending Applications | 92 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13729747
[patent_doc_number] => 20180369341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 16/127393
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16127393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/127393 | Pharmaceutical Compositions | Sep 10, 2018 | Abandoned |
Array
(
[id] => 16282719
[patent_doc_number] => 20200276321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => COMPOSITION AND METHOD FOR A PREBIOTIC DELIVERY SYSTEM TARGETED TO PROBIOTIC BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/645892
[patent_app_country] => US
[patent_app_date] => 2018-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/645892 | COMPOSITION AND METHOD FOR A PREBIOTIC DELIVERY SYSTEM TARGETED TO PROBIOTIC BACTERIA | Sep 8, 2018 | Pending |
Array
(
[id] => 16686822
[patent_doc_number] => 20210069297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => VISCOUS COMPOSITION FOR TREATING ISCHEMIA
[patent_app_type] => utility
[patent_app_number] => 16/642273
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642273 | VISCOUS COMPOSITION FOR TREATING ISCHEMIA | Aug 30, 2018 | Abandoned |
Array
(
[id] => 19179939
[patent_doc_number] => 11986514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-21
[patent_title] => Compositions for treating macular edema
[patent_app_type] => utility
[patent_app_number] => 16/642642
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 10333
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642642 | Compositions for treating macular edema | Aug 30, 2018 | Issued |
Array
(
[id] => 16930903
[patent_doc_number] => 20210196792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => IMMUNOREGULATORY MOLECULES AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/642769
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642769 | Immunoregulatory molecules and uses therefor | Aug 30, 2018 | Issued |
Array
(
[id] => 13733165
[patent_doc_number] => 20180371050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => MURINE ANTI-NY-ESO-1 T CELL RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 16/115969
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/115969 | Murine anti-NY-ESO-1 T cell receptors | Aug 28, 2018 | Issued |
Array
(
[id] => 16612092
[patent_doc_number] => 20210030745
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-02-04
[patent_title] => Methods and Compositions for Treating Vasomotor Symptoms
[patent_app_type] => utility
[patent_app_number] => 16/114661
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16114661
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/114661 | Methods and compositions for treating vasomotor symptoms | Aug 27, 2018 | Issued |
Array
(
[id] => 16612092
[patent_doc_number] => 20210030745
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2021-02-04
[patent_title] => Methods and Compositions for Treating Vasomotor Symptoms
[patent_app_type] => utility
[patent_app_number] => 16/114661
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16114661
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/114661 | Methods and compositions for treating vasomotor symptoms | Aug 27, 2018 | Issued |
Array
(
[id] => 13955617
[patent_doc_number] => 20190054152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => Composition and Nutritional Supplement Made Therefrom
[patent_app_type] => utility
[patent_app_number] => 16/106348
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106348
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106348 | Composition and Nutritional Supplement Made Therefrom | Aug 20, 2018 | Pending |
Array
(
[id] => 19855553
[patent_doc_number] => 12258376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Fusion protein of DCTN1 protein with RET protein
[patent_app_type] => utility
[patent_app_number] => 16/640955
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 18889
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640955
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640955 | Fusion protein of DCTN1 protein with RET protein | Aug 19, 2018 | Issued |
Array
(
[id] => 18427611
[patent_doc_number] => 11672811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Materials and methods for suppressing and/or treating bone related diseases and symptoms
[patent_app_type] => utility
[patent_app_number] => 16/635769
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 7395
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635769 | Materials and methods for suppressing and/or treating bone related diseases and symptoms | Aug 1, 2018 | Issued |
Array
(
[id] => 15960575
[patent_doc_number] => 20200164039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => METHODS OF PROTECTING VASCULAR INTEGRITY INDUCED BY TARGETED RADIATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/633854
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633854 | Methods of protecting vascular integrity induced by targeted radiation therapy | Jul 25, 2018 | Issued |
Array
(
[id] => 18391400
[patent_doc_number] => 20230159618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/632762
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -80
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632762 | ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF | Jul 24, 2018 | Abandoned |
Array
(
[id] => 13519205
[patent_doc_number] => 20180311145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => Method Or Improving Selective Catabolysis In Cells Of Keratin Surfaces
[patent_app_type] => utility
[patent_app_number] => 16/034157
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034157
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034157 | Method or improving selective catabolysis in cells of keratin surfaces | Jul 11, 2018 | Issued |
Array
(
[id] => 13519529
[patent_doc_number] => 20180311307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => THERAPEUTIC VITAMIN D CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/034046
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034046 | Therapeutic vitamin D conjugates | Jul 11, 2018 | Issued |
Array
(
[id] => 17586560
[patent_doc_number] => 11324802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => C3 fusion protein and methods of making and using thereof
[patent_app_type] => utility
[patent_app_number] => 16/618021
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 34130
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618021 | C3 fusion protein and methods of making and using thereof | May 29, 2018 | Issued |
Array
(
[id] => 13840541
[patent_doc_number] => 20190023755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/992039
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/992039 | Compositions and methods of using islet neogenesis peptides and analogs thereof | May 28, 2018 | Issued |
Array
(
[id] => 13565887
[patent_doc_number] => 20180334491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => VARIANT SERUM ALBUMIN WITH IMPROVED HALF -LIFE AND OTHER PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 15/989985
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989985
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989985 | Variant serum albumin with improved half-life and other properties | May 24, 2018 | Issued |
Array
(
[id] => 13410291
[patent_doc_number] => 20180256688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => METHODS AND COMPOSITIONS FOR IMPROVED COGNITION
[patent_app_type] => utility
[patent_app_number] => 15/988216
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/988216 | Methods and compositions for improved cognition | May 23, 2018 | Issued |
Array
(
[id] => 16778022
[patent_doc_number] => 20210115100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => VARIANTS OF HUMAN BMP7 PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/608015
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608015 | Variants of human BMP7 protein | Apr 19, 2018 | Issued |